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ABSTRACT 
 
The Chromatin Immunoprecipiation (ChIP) provides a powerful technique for identifying the in vivo association of 
transcription factors with regulatory elements. However, obtaining meaningful information for promoter interactions 
is extremely challenging when the promoter is a member of a class of highly homologous elements. Use of PCR 
primers with small numbers of mutations can limit cross-hybridization with non-targeted sequences and distinguish a 
pattern of binding for factors with the regulatory element of interest. In this report, we demonstrate the selective in vivo 
association of NF-κB, p300 and CREB with the human Iγ1 promoter located in the intronic region upstream of the Cγ1 
exons in the immunoglobulin heavy chain locus. These methods have the ability to extend ChIP analysis to promoters 
with a high degree of homology. 
 
 
INTRODUCTION 
 
The association of cellular proteins with chromatin can 
elicit a range of cellular responses involving 
transcriptional modulations, initiation or attenuation of 
DNA replication and in specific cases, the induction of 
non-homologous recombination during lymphocyte 
development and activation. The Chromatin 
Immunoprecipitation (ChIP) assay has proved to be an 
invaluable tool for identifying transcription factors 
associated with promoters at distinct stages of gene 
activation. This assay, for the most part, has refined in 
vitro and transfection studies that evaluate the capacity 
of a distinct factor to bind an identified sequence within 
a known promoter by demonstrating an in vivo 
association with the same binding site in chromatin 
reviewed in (1, 2). Accordingly, promoters that have the 
appropriate factor binding sites may be restricted, via 
chromatin organization, from interacting with a 
transcription factor under specific cellular conditions. 
 
In a humoral immune response, multiple genes go 
through a cycle of transcriptional activation and 
attenuation in the course of B cell differentiation into 
antibody-producing cells (reviewed in (3, 4). A critical set 
of genes known to be directly regulated by activation 
signals at the transcriptional level are the 
immunoglobulin (Ig) constant region genes within the Ig 
heavy chain (CH) locus. In the human, there are nine Ig 
heavy chain constant region genes, Cµ, Cδ, Cγ1, Cγ2, 
Cγ3, Cγ4, Cα1, Cα2 and Cε, that encode the heavy chain 
polypeptides for the IgM, IgD, IgG1-4, IgA1-2 and IgE 
antibodies, respectively. The Cγ, Cα and Cε heavy chains 
are generated via class switch recombination (CSR) after 
antigen and / or T cell stimulation and thus contribute to 
the antibody diversity required for a comprehensive 
humoral response (reviewed in (3)). Upon B cell 
activation and prior to undergoing CSR, this group of 
genes becomes transcriptionally active due to the 
presence of intronic, or I region promoters located 
upstream of the different CH exons. The I region     
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promoters within a subclass are highly homologous, yet 
have unique responses to diverse stimuli and thus 
transcriptional activation of the different I region 
promoters can greatly influence the antibody profile of a 
specific response (5-11). 
 
Our laboratory’s focus has been to understand the basis 
for Iγ promoter activity in response to signals through 
the CD40 pathway (12-14). This pathway is triggered by 
cognate interactions with CD40 ligand (CD40L or CD154) 
expressed on activated CD4+ T cells and has been shown 
to be highly dependent on NF-κB (15-17). We, and 
others, have observed that the different Iγ promoters 
respond distinctly differently to CD40 signals both in B 
cell lines and in primary human B cells (12, 18-20). In 
particular, there is a very strong Iγ1 transcriptional 
response and a very restricted Iγ4 response. Iγ3 and Iγ2 
promoters give variable responses depending on the cell 
line and stimulus. These observations are unexpected 
given the fact that the proximal promoters are 
approximately 97% identical within the subclass. We 
have analyzed the different Iγ promoters in transfection 
and reporter assays and found discrete differences in 
transcriptional responses that are sequence-specific (13). 
In particular, we identified a 36bp region in the Iγ1 
promoter that contained CREB/ATF binding sites and an 
adjacent putative NF-κB binding site (κB6 site) that was 
absent in the Iγ3 promoter. We previously demonstrated 
that the CREB/ATF binding sites function as an 
“amplifier” element such that its insertion into the Iγ3 
promoter induces a response greater than that seen with 
the Iγ3 promoter alone (13). Our recent work extended 
this finding and demonstrated a critical role for the NF-
κB site in Iγ1 promoter activity in the Ramos B cell line 
(14). Taken together, our transfection and reporter data 
revealed important differences in Iγ promoter responses 
to CD40 signaling, however it was evident from the 
different responses obtained with the reporter constructs 
compared to the endogenous promoters, that a major 
form of Iγ promoter regulation was at the chromatin 
level. 
 
Our recent experimental goal focused on determining 
whether binding at the different κB sites in the Iγ1 
promoter was critical for in vivo expression. Also, we 
wished to determine whether the interaction between 
NF-κB binding at the κB6 site, with proteins bound at the 
adjacent CREB/ATF site and/or upstream κB3-5 sites, 
was necessary for Iγ1 expression in both Ramos B cells 
and as an extension, primary B cells. In order to study 
the CD40 regulation of Iγ1 transcription at the chromatin 
level several obstacles had to be overcome. First, it was 
clear that ChIP assays would give the most accurate 
pattern of both NF-κB and co-activator binding in the Iγ1 
promoter, however these experiments have inherent 
problems that needed to be solved empirically. Second, 
only a small number of cells in the Ramos B cell line 
actually respond to exogenous signals and express Iγ 
transcripts, thus in order to obtain meaningful results, 
we had to use peripheral B cells from isolated blood for 
our ChIP studies. Finally, we had to utilize PCR 
protocols that would distinguish the Iγ1 promoter from 
the other three highly homologous Iγ subclass promoters 
in order to be able to convincingly ascribe binding to the 
Iγ1 promoter. Here, we describe, in-depth, our methods 
for identifying the in vivo association of specific 
transcription factors with a single promoter region that is 
highly homologous to three other promoters. 
Furthermore, we outline our procedure for carrying out 
ChIP on primary human B cells. 
 
MATERIALS AND METHODS 
 
Isolation and activation of human CD19
+ B cells 
 
Blood products were prepared by the NBAH Blood 
C e n t e r  a t  R o b e r t  W o o d  J o h n s o n  U n i v e r s i t y  M e d i c a l  
Center or the New York Blood Center from peripheral 
blood samples healthy donors. Mononuclear cells 
(PBMCs) were separated by Ficoll-Hypaque gradient 
centrifugation. Blood products were diluted 1:1 in RPMI 
1640 media layered over Ficoll-Hypaque, and spun for 30 
min at 2000 RPM. Buffy coat (the leukocyte layer) was 
aspirated from the gradient and washed for 30 min at 
1500 RPM in RPMI 1640 media. Total leukocytes were 
resuspended in 1X PBS containing 2% FBS and B cells 
were removed via biomagnetic separation by incubating 
for 1 hr at 4°C with anti-CD19-conjugated 
superparamagnetic beads provided by Dynal (Lake 
Success, NY). Beads were washed five times with 1X PBS 
containing 0.1% BSA to remove non-specifically bound 
cells, and plated in 10 mls RPMI 1640 media 
supplemented with 10% heat inactivated fetal calf serum 
(FCS), 50U/ml penicillin, 50 µg/ml streptomycin and 
1mM L-glutamine at 37°C / 5% CO2 for 12 hr. Media was 
collected and cells were detached from beads using 30 µl     
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Dynal anti-CD19 DETACHabead (diluted 100-fold in 
RPMI containing 1% FBS) for 30 min at 25°C. Beads were 
washed and the supernatant containing CD19+  B cells 
was collected. To deplete the population of “activated” B 
cells, IgG+ B cells were removed from the total CD19+ B 
cell population by negative selection. Specifically, anti-
IgG coated 100 mM plates were prepared with 5 mls 
coating buffer (0.5M Tris-Cl pH 9.5, 0.15M NaCl) 
containing 25 g/ml human anti-IgG (catalog # 2040-07, 
Southern Biotech) overnight at 4°C. CD19+ B cells from 
multiple units (up to 1 x 108 c e l l s )  w e r e  p o o l e d  a n d  
plated in 10 mls of complete RPMI media, on the anti-
IgG coated petri dishes for 30 min at 25°C. Following 
incubation, IgG- B cells were analyzed by flow cytometry 
to verify the success of the isolation procedure.  
 
Flow cytometry 
 
To analyze lymphocyte populations relative to purity at 
different stages of the isolation procedure, cells were 
incubated with specific antibodies and surface 
expression monitored by flow cytometry. Specifically, 1 x 
105 B cells were washed in 3% FCS/0.1% NaN3 /1X PBS 
followed by incubation for 10 min at 4°C with 5 g heat 
aggregated IgG to inhibit non-specific binding. Cells 
were incubated for 45 min at 4°C with saturating 
amounts of fluorescein isothiocyanated (FITC)-
conjugated or biotin-conjugated mAbs against human 
CD20 (cat# 169-020) using 80 µl of 10 µg/ml (Ancell, 
Bayport MN) IgM (cat# 9020-08) using 80 µl of 20µg/ml, 
IgD (cat# 2030-02) using 80 µl of 10µg/ml, or IgG (cat# 
2040-01) using 80 µl of 20µg/ml (Southern Biotechnology 
Associates, Birmingham, AL). Biotin-conjugated samples 
were further incubated with phycoerythrin-conjugated 
streptavidin (cat# 253-050) using 20 µl of a 1:10 dilution 
for 45 min at 4°C. Cells were washed and fixed with 500 
µl of 1% paraformaldehyde in 1X PBS. Cells were 
analyzed using FACScan (Becton Dickinson, Mountain 
View, CA). 
 
Primary B cell stimulation 
 
The total population of CD19+/IgG- B cells collected from 
blood isolations were divided equally and plated in 2-5 
ml of complete RPMI in a 6-well dish. The volume of 
media used for cultures was determined by the number 
of cells obtained with each isolation, with a final 
concentration of approximately 1 x 107 /ml. Cultures were 
either unstimulated or supplemented with 0.5 µg/ml of 
sCD40L for 2hr, and harvested for chromatin 
immnoprecipitation assays. To obtain sufficient 
CD19+/IgG- B cells for chromatin immunoprecipitations, 
multiple blood isolations were performed and the 
CD19+/IgG- B cells were pooled. In the event that multiple 
blood units could not be obtained from blood sources 
within a 24 hr period, individual blood units were 
processed. Isolated CD19+/IgG- B cells were stimulated as 
described above, harvested for formaldehyde 
crosslinking, and snap-frozen after washing with PBS. To 
continue with chromatin immunoprecipitation assays, 
these cell pellets were thawed and pooled to obtain a 
final cell number of 5 x 107  primary B cells per 
experiment. 
 
EMSA to confirm B cell activation 
 
To determine whether the stimulation conditions were 
sufficient for primary B cell activation, 5 x 106 primary 
IgM+/IgG- B cells were removed from culture at 2 hr and 
prepared for nuclear extracts using a modification of 
D i g n a m ’ s  m e t h o d  ( 2 1 ) .  C e l l s  w e r e  w a s h e d  o n c e  i n  1 X  
PBS, and resuspended in 400 µl ice-cold buffer A (10 mM 
Hepes, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM 
EGTA, 1 mM DTT, 0.5 mM PMSF, 2 µM aprotinin, 2 µM 
pepstatin A). After incubation on ice for 10 min NP-40 
was added to a final concentration of 0.6%, and nuclei 
isolated by centrifugation at 14,000 rpm for 30 s. Nuclei 
were resuspended in 50 µl ice- cold buffer C (20 mM 
Hepes, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 
mM DTT, 0.5 mM PMSF, 2 µM aprotinin, 2 µM pepstatin 
A). Samples were kept on ice for 30 min, with brief 
vortexing every 5 min and centrifuged at 14,000 rpm for 
10 min. Protein concentration was determined using the 
Bradford Assay (BioRad). 
 
CD40 signaling in B cells results in an influx of NF-κB 
into the nucleus upon activation, therefore the nuclear 
extracts were incubated with a double-stranded NF-κB 
5’agt tga ggg gac ttt ccc agg c 3’ competitor consensus 
DNA fragment purchased from Promega Corporation 
and end labeled with [γ-32P] ATP, to visualize activation 
of NF-κB. Binding reactions were prepared using 4 µg 
extract, 1 µg poly dI-dC in binding buffer (10mM Tris Cl 
pH 7.5, 50mM NaCl, 1mM DTT, 1mM EDTA, 5% 
glycerol). 3-4 x 104 cpm was added to reactions and 
incubated 20 min at 25°C. In order to confirm the     
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presence of NF-κB, a supershift assay was performed 
using 1 µl of anti-p50 sera (gift of Dr. N. Rice, National 
Cancer Institute, Bethesda, MD), and incubating the 
above mix an additional 1.5 h at 25°C prior to addition of 
the probe. Samples were loaded on a 6% acrylamide gel 
and visualized by autoradiography.  
 
ChIP assay using CD19
+ B cells 
 
The chromatin immunoprecipitation (ChIP) assay that 
we devised for our work was an extension of previous 
protocols (22, 23) with some specific modifications. 
Briefly, 5 x 107  primary B cell cultures were harvested 
and diluted to 100 ml with 37°C media and cross-linked 
by the addition of one-tenth volume of 11% 
formaldehyde in 0.1 M NaCl, 1 mM EDTA, 0.5 mM 
EGTA and 50 mM Hepes, pH 8.0 in growth medium for 
5 min at RT, before addition of glycine to a final 
concentration of 0.125 M. After washing 2X with ice-cold 
PBS containing 1X protease inhibitor cocktail (PIC) 
(Sigma) cells were resuspended in 25 mls ice-cold cell 
lysis buffer 1 (10mM Tris-CL pH 8.0, 10mM EDTA, 
10mM Na-Butyrate, 0.5mM EGTA, 0.25% Triton X-100, 
1X PIC, 1 mM PMSF) and incubated on ice 10 min. 
Nuclei were recovered by centrifugation and 
resuspended in lysis buffer 2 (0.2M NaCl, 10mM Tris-CL 
pH 8.0, 1mM EDTA, 0.5mM EGTA, 1X PIC, 1 mM PMSF) 
and incubated 10 min. Samples were centrifuged and 
resuspended in 2 ml sonication buffer (10 mM Tris-Cl, 
pH 8.0, 1 mM EDTA, 0.5 mM EGTA). Chromatin was 
sonicated 12 rounds for 20 s using a 250 Branson Sonifier 
(30% output) alternating with 30 s incubations on 
ETOH/ice. Chromatin was centrifuged 10 min at 14,000 
R P M  t o  p e l l e t  d e b r i s ,  a n d  s t o r e d  a t  - 8 0 ° C .  C h r o m a t i n  
samples were pre-cleared for 1-2 h at 4°C by adding 50 µl 
Protein A/ssDNA-agarose beads (Upstate 
Biotechnology), followed by incubation with antibody in 
a 10-fold dilution of 1 X RIPA buffer (140mM NaCl, 1% 
Triton X-100, 0.1% deoxycholate, and 1mM PMSF) at 4°C 
overnight. Immune complexes were recovered at 4°C for 
1 h using 60 µl Protein A/ss DNA agarose beads. 
Complexes were washed five times with IP1 (0.1% SDS, 
1% Triton X-100, 2 mM EDTA, 20 mM Tris, pH 8.0, 150 
mM NaCl), once with IP2 (0.1% SDS, 1% Triton X-100, 2 
mM EDTA, 20 mM Tris, pH 8.0, 500mM NaCl), and twice 
with Tris-EDTA pH 8.0. Immunoprecipitation reactions 
and input chromatin were digested with 200 µg/ml 
RNase A for 1 h and 200 µg/ml proteinase K in TE with 
0.5% SDS for 2 h at 55°C. Crosslinks were reversed 
overnight at 65°C. Samples were extracted once with 
phenol/chloroform and once with chloroform/isoamyl 
alcohol, ETOH precipitated and resuspended in 12 µl TE.  
 
Sequence-specific PCR with ChIP products 
 
Due to the high sequence conservation of the four Iγ 
subclass promoters it was difficult to selectively amplify 
only the Iγ1 promoter region using standard PCR 
techniques. Therefore, in order to distinguish Iγ1 from 
the remaining subclasses, PCR was carried out with 
primers that contained a minimum number of 4 naturally 
occurring base alterations and 3-4 additional changes 
that were intentionally introduced into the primer 
sequence. This level of mispriming still allowed 
amplification of the Iγ1 promoter sequence. To test the 
specificity of primers, PCR was performed using either 
0.2 ng purified HindIII-BamHI Iγ subclass promoter 
sequence, 1 µl of 1:200 dilution of input chromatin, 3 µl 
of undiluted or 10-fold serial diluted immunoprecipitant 
in a 50 µl reaction containing 10 mM Tris Cl (pH 8.1), 1.5 
mM MgCl2, 50 mM KCl, 0.1% Triton X-100, 5% DMSO, 
0.2 mM dNTPs, 2.5 U Taq (Promega) and 100 ng of 5’ and 
3’ primers: Iγ non-specific- 5’gcc ctc tga ccc aga aac c 3’; 
5’cct tcc tgt tct ggc gag gt 3’; Iγ1 specific- 5’ tcc atg tag tgc 
cgg aca cga ccc cat 3’; Iγ1 WT 5’ tcc atg tgg ggc cgg cct 
cga ccc cat 3’; Iγ1 Δ 1bp 5’ tcc atg tgg tgc cgg cct cga ccc 
cat 3’; Iγ1 Δ 2bp 5’ tcc atg tgg tgc cgg cca cga ccc cat 3’; 
Iγ1 Δ 3bp 5’ tcc atg tgg tgc cgg aca cga ccc cat 3; IgHG1- 
5’ctc cac caa ggg ccc atc ggt 3’; 5’caa atc ttg tga caa aac tca 
cac at 3’. Amplification of all reactions was for 35 cycles, 
with a hot-start at 3 min at 92°C, 30 s at 92°C, 45 s at 
56°C, 45 s at 72°C, and 3 min at 72°C. Final PCR 
amplifications were subjected to gel electrophoresis and 
bands were quantified using Kodak imaging software. 
 
RESULTS AND DISCUSSION 
 
Isolation and characterization of CD19
+ human B cells 
from blood 
 
Successful ChIP is highly dependent on having sufficient 
starting material to carry out a number of 
immunoprecipitation reactions using chromatin from the 
same source of cells. Therefore, using primary human B 
cells in this assay is highly challenging given the     
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relatively low numbers of isolated B cells from 
peripheral blood. Also, since our goal was to analyze 
factor binding before and after activation through CD40, 
it was critical that the isolated B cells were non-activated 
prior to isolation. We therefore set out to isolate CD19+ 
IgG- B cells to obtain a population of B cells that were 
predominantly IgM+/IgD+. From 500 ml/unit of human 
blood, we were able to isolate an average of 3.4 x 107 B 
cells/unit or 4.9% of the total peripheral blood 
mononuclear cells (PBMCs) (Table 1). 
 
Table 1: Leukocyte and B cell yields from human blood. 
Cell 
population 
Range of cells obtained 
(total units =10) 
Avg. cell 
number 
% 
yield 
PBMCs  2.5 x 108 – 1.5 x 109  7.0 x 108  100% 
CD19+  1.5 x 107 – 9.5 x 107  4.0 x 107  5.7% 
CD19+/IgG- ND  3.4 x 107  4.9% 
 
The positively selected population was shown to be 
approximately 98% CD20+ (pan B cell marker). We 
selected to use anti-CD20 antibody to measure successful 
B cell isolation, since use of the CD19+ magnetic beads 
may cause CD19+ epitopes to be obscured. Further 
purification of this population by negatively selecting 
IgG+ B cells produced cells that were 87% IgM+ and 89% 
IgD+ (Fig. 1). 
 
 
Fig. 1: Purification of a IgM+/IgD+ population of primary B cells. CD19+ 
isolated IgM+/IgG- peripheral B cells were analyzed for surface expression 
of CD20 and IgG (upper panel). IgG, IgM, and IgD expression was 
determined following subsequent negative selection using anti-IgG 
antibody (lower panel). Percentages of positively stained cells are 
indicated in the right corner of each histogram. The stippled line 
represents the isotype control for each antibody. 
The percentage of IgG+ B cells left in the final population 
was below that observed with the isotype control and 
supported out assertion that the starting population was 
predominantly IgM+/IgD+ B cells (Table 2). 
 
Table 2: Phenotypic analysis of B cell populations. 
Surface marker  Average expression 
CD20 98% 
IgG- pre selection  9.3% 
IgG- post selection  3.7% 
Isotype control  5.3% 
 
To obtain sufficient numbers of CD19+/IgM+ B cells for 
each ChIP assay, units were pooled prior to stimulation. 
Purified CD19+/IgG- B cells were stimulated with soluble, 
trimerized CD154 for 2 hr. Because of our interest in 
analyzing the interaction of Rel/NF-κB subunits with 
chromatin, it was necessary to confirm that the 
stimulation conditions were, in fact, inducing NF-κB 
activity. To this end, EMSAs were carried out with 
nuclear extracts from resting and activated B cells with 
and without antibody to the p50 NF-κB subunit. As seen 
in Figure 2, prior to activation there is a measurable level 
of NF-κB activity in the B cells (lane 1). However, upon 
activation there is a significant increase of binding 
activity (lane 2) and a considerable amount of the 
binding activity is super-shifted with anti-p50 antibodies 
(lane 3). This result indicated that under the stated 
conditions of CD40 activation, there was a marked 
increase in NF-κB activity in the primary CD19+/IgG- B 
cells. 
 
In addition to the intrinsic challenges of the ChIP 
protocol (reviewed in (24, 25)) our experiments had the 
added difficulty of establishing binding specificity to a 
single promoter within a class of four highly 
homologous gene promoters. As shown in Figure 3, 
these promoters all contain multiple NF-κB sites; four of 
them (sites 3-6) have been shown to be active in 
regulating transcription in transfection studies in both     
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mouse and human B cells (15, 26, 27). It was critical for 
the questions that we were asking, i.e. whether binding 
at the Iγ1 locus occurred prior to, or after activation, to 
be able to attribute in vivo NF-κB/rel, CREB, and p300 
binding to the Iγ1 and not the Iγ2-4 promoters. 
Therefore, once the DNA was isolated from chromatin 
we carried out PCR with primers designed to distinguish 
between Iγ1 and Iγ4 based on size and between Iγ1 and 
Iγ3 based on differential amplification. This protocol was 
adapted from the mutagenically separated PCR (MS-
PCR) technique in which variable length allele-specific 
primers are used to identify single allelic point mutations 
(14, 28, 29). In addition to size differences in the Iγ1 and 
Iγ4 3’ primers, an additional base change was introduced 
to reduce potential cross-reactions between near identical 
sequences thereby increasing the specificity of the 
reaction. We generated a 5’ primer that recognized only 
the Iγ1, Iγ3, and Iγ4 promoter sequences (I-1/4) 
sequences and two variable length 3’ primers (I-1 and I-
4) that amplified different sized Iγ sequences 
corresponding to Iγ1 or Iγ4 (Fig. 3B). This approach 
proved to be unfeasible for quantitation-based 
experiments since the efficiency of amplification of the 
two reactions was found to be markedly different 
( a r r o w s ,  F i g .  3 B ) .  A d d i t i o n a l  p r i m e r  p a i r s  w e r e  t e s t e d  
and they too presented quantification problems due to 
the preferential amplification of individual products 
(data not shown). 
 
To address the issues presented with MS-PCR, additional 
primer sets were generated, for which each Iγsubclass 
was amplified in a separate reaction using the same 5’ 
primer (ChIP 5’), but distinct 3’ primers that hybridized 
to a region of each promoter that had a minimum of 
three base pair differences among the sequences (ChIP 3’ 
Iγ1 and ChIP 3’ Iγ4) (Fig. 4A). Again, additional non-
templated base changes were added within the primer 
sequences to limit cross-reactivity and amplification of 
multiple subclasses (28). As shown in Figure 4B, The 
number of induced changes was determined by testing 
various 3’ primers, denoted Iγ1Δ3, Δ2, and Δ1 bp, in PCR 
reactions containing each Iγ subclass promoter region as 
a cloned DNA template. In order to eliminate 
amplification of all other subclasses, a 3’ primer, 
containing at least 2 additional bp changes, was required 
(upper panel). However, to eliminate potential primer-
dimer products and reduce the GC-stretches, another 3’ 
primer was generated that contained 4 induced 
alterations. Using this Iγ1 promoter-specific primer the 
promoter sequences of the other three Iγ subclasses 
failed to amplify (Fig. 4C). The size of the fragment 
generated with this set of Iγ1-specific primers (~380bp) 
precluded us from using these primers effectively in 
qPCR. Thus, we had to expand our PCR analysis by 
carrying out dilution PCR to determine the amount of 
enrichment with specific antibodies under distinct 
conditions of stimulation.     
 
 
Fig. 2: NF-κB activity is upregulated in response to CD40 signaling. NF-κB 
consensus oligonucleotide was incubated with extracts from IgM+/IgG- 
peripheral B cells either unstimulated (lane 1) or stimulated for 2 h with 
0.5 µg/ml sCD40L (lanes 2 and 3). Supershifting was performed by 
subsequent incubation with a p50 antibody (lane 3). NF-κB complex is 
indicated by the arrow.     
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Fig. 3: Nucleotide sequence of the four human Iγ proximal promoter regions. (A) Alignment of the four Iγ subclass full length proximal promoters is 
shown, with nucleotide variances indicated in bold. NF-κB binding sites are denoted by shading. Initial primer sequences used for ChIP PCR 
amplification are indicated by arrows. Numbering is relative to the Iγ1 transcriptional start site defined by Sideras et al. (30). (B) Total chromatin from 
CD19+ B cells was amplified using the 5’-I-1/4 primer and either the 3’-1-1 primer (lane 1), the 3’I-4 primer (lane 2) or both the 3’ I-1 and the 3’I-4 
primers. Products representing the Iγ1 and Iγ4 promoters were separated on a 1.5% TBE gel. 
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Fig. 4: The Iγ1 proximal promoter is selectively amplified with PCR. (A) 
Shown is a schematic of the Iγ1 proximal promoter sequence from -191 
to +288 (see Fig. 2), with arrows indicating the forward and reverse 
primers used to amplify ChIP products. Non-templated nucleotide 
substitutions, introduced into the 3’ primer sequence, are denoted in 
lower case. NF-κB sites 3 through 6 are indicated by ovals, whereas the 
36 bp sequence is enclosed by a rectangle. (B)  PCR amplification of 
cloned DNA containing the specific Iγ promoter sequences was performed 
using Iγ1-specific primers with exchange of 0 (lane 1), 3 (lane 2), 2 (lane 
3) and 1 (lane 4) non-templated nucleotides in the Iγ1 sequence. (C) PCR 
amplification of cloned DNA sequences of Iγ1, Iγ2, Iγ3 and Iγ4 promoter 
sequences using the ChIP Iγ1-5’ and Iγ1-3’ primers (Fig. 3C used with 
permission, The Journal of Immunology 2005; 175:4499-4507). 
 
The objective of our experiments, using the selective 
primers, was to analyze NF-κB, CREB and p300 binding 
specifically to the Iγ1 promoter in resting and CD40-
activated primary human B cells. Because the strength of 
the Iγ1 promoter appears to be higher than the other Iγ 
subclass promoters in both primary B cells and a number 
of B cell lines, and the fact that we observed transcription 
factor binding in vitro, led us to question whether there 
was selective binding to the Iγ1 promoter in vivo. Using 
the ChIP assay with chromatin purified from resting and 
CD40-stimulated CD19+IgG- B cells we were able to see a 
distinct difference in binding of CREB and p300 in 
unstimulated versus stimulated B cells (Fig. 5).  
 
Fig. 5: Co-activator binding is enhanced in CD40-activated B cells. 
Chromatin was prepared from resting IgM+/IgG- peripheral B cells that 
was either unstimulated (upper panel) or stimulated for 2 h with 0.5µg/ml 
sCD40L. Immunoprecipitation was carried out with antibodies specific for 
p50, CREB and p300. Eluted DNA was amplified with Iγ1-specific primers 
(left panels) or control IgHG1 primers (left panels). 10-fold serial dilutions 
of the chromatin (starting with a 1:10 dilution of the immunoprecipitated 
product) were used to demonstrate linearity of the PCR reaction. Products 
were quantified by determining the fold increase signal over the “no 
antibody” signal (used with permission, The Journal of Immunology 2005; 
175:4499-4507). 
 
Specifically, we observed that CREB binding was more 
pronounced in unstimulated B cells compared to 
stimulated B cells suggesting that CREB binds on this 
promoter prior to and after CD40 activation. With CD40 
signaling there is a distinct loss of CREB signal but an 
enhancement of co-activator p300 binding indicating a 
recruitment of this factor to the Iγ1 promoter (compare 
upper and lower panels). As noted above, quantitation of 
the bands were carried out using dilution PCR to assess 
the enrichment of the Iγ1 band in the different samples. 
 
In conclusion, using a modified ChIP protocol with 
primary human B cells we were able to show selective 
binding of transcription factors and co-activators at the 
Iγ1 promoter. Importantly, with this assay we also 
demonstrated an in vivo change in factor binding upon 
stimulation of naïve B cells upon activation through the 
CD40 signal transduction pathway. 
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PROTOCOLS 
 
1.  Transfer 5 x 107 cells and dilute to 100 ml volume with 37°C pre-warmed media, add 10 ml of 11% formaldehyde 
solution while swirling.  
2.  Incubate at 37°C 7-10 min, stop crosslinking by adding glycine to a final concentration of 0.125M, incubate for 5 
minutes on ice.  
3.  Harvest cells at 1250 RPM for 5 minutes and wash twice with cold 1X PBS. 
4.  Pellet cells and resuspend in 25 ml of Lysis solution 1, incubate on ice 10 minutes, with periodic mixing.  
5.  Pellet cells at 2500 RPM and resuspend pellet in 25 ml lysis solution 2, to ensure complete resuspension, add 1 ml 
to pellet first and pipet up and down, add remaining 24 ml and place at 4°C on rocker.  
6.  Pellet and discard supernatant, resuspend pellet in 2 mls sonication buffer.  
7.  Add 200 mg of acid washed glass beads for sonication. 
8.  Place tube in ethanol/ice beaker to keep cold during sonication, position tube so that probe is near the bottom, but 
not touching. This will minimize frothing of samples. 
9.  Sonicate for 8-12 rounds, for 20 secs at 30% output, ice for 1 minute between each interval. Change ice frequently 
to ensure proper cooling of samples. 
10.  Spin chromatin at 14K RPM for 10 minutes to pellet debris. 
11.  Aliquot samples 200 µl and and continue with assay, or store at -80°C. Set aside 20 µl to use as input. 
12.  Thaw samples and dilute 1:10 with 1X RIPA buffer, add 50 µl of Protein A/ssDNA and pre-clear chromatin for 1 
hour on a rotator at 4°C. 
13.  Spin at 1200RPM to remove beads and transfer supernatant to a fresh tube. 
14.  Add 2-4 µg of the desired antibody, rotate overnight at 4°C. 
15.  Add 60 µl Protein A/ssDNA slurry to each sample and rotate 1 hr.  
16.  Spin at 1200 RPM for 3 minutes to pellet beads. 
17.  Wash 5 times with IP1, with 5 minute rotation at RT.  
18.  Wash once with IP2, with a 5 minute rotation, and twice with TE.  
19.  To reverse crosslinke, bring bead pellet up to 400 with TE and add 8 µl RNAse A (10mg/ml) to final of 200 µg/ml, 
incubate 1 hour at 55°C. *Remove TC input samples from -80°C and reverse X-links at this time.  
20.  Add 20 µl of 10% SDS (FC 0.5%) and 8 µl Proteinase K (10mg/ml) and incubate 2-3 hours at 55°C, move to 65°C 
overnight.  
21.  Phenol chloroform samples once, chloroform/isoamyl once, and ethanol precipitate sample.  
22.  Resuspend final IP product in 12 TE, use 3µl per 50 µl PCR reaction. 
 
Chromatin immunoprecipitation assay 
Formaldehyde solution  Lysis solution 1  Lysis solution 2  Sonication buffer 
11% formaldehyde 
0.1M NaCl 
1mM EDTA 
0.5mM EGTA 
50mM HEPES, pH 8.0 
10mM Tris-CL pH 8.0 
10mM EDTA 
10mM Na-Butyrate, 0.5mM 
EGTA 
0.25% Triton X-100 
1X PIC 
1 mM PMSF 
0.2 M NaCl 
10 mM Tris-Cl, pH 8.0 
1 mM EDTA 
0.5 mM EGTA 
1X PIC 
1 mM PMSF 
10 mM Tris Cl, pH 8.0 
1 mM EDTA 
0.5 mM EGTA 
2X RIPA  IP Wash 1  IP Wash 2   
280 mM NaCl 
2% Triton X-100 
0.2% Deoxycholate 
2 mM PMSF 
0.1% SDS 
1% Triton X-100 
2 mM EDTA 
20 mM Tris, pH 8.0 
150 mM NaCl 
0.1% SDS 
1% Triton X-100 
2 mM EDTA 
20 mM Tris, pH 8.0 
500mM NaCl 
 
 